RESPONSE BIOMEDICAL CORP

Quarterly Report for period ending 2016-09-30

Quarterly Report for period ending 2016-06-30

Quarterly Report for period ending 2016-03-31

Annual Report for period ending 2015-12-31

Annual Report for period ending 2015-12-31

Quarterly Report for period ending 2015-09-30

Quarterly Report for period ending 2015-06-30

Quarterly Report for period ending 2015-03-31

Annual Report for period ending 2014-12-31

Quarterly Report for period ending 2014-09-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of termination of registration of a class of securities under Section 12(g)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Order Granting Confidential Treatment

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Order Granting Confidential Treatment

Order Granting Confidential Treatment

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Shuster Lewis: Statement of changes in beneficial ownership of securities

HOLLER ANTHONY F: Statement of changes in beneficial ownership of securities

Thompson Peter A.: Statement of changes in beneficial ownership of securities

Adams William J.: Statement of changes in beneficial ownership of securities

KEEGAN JOSEPH D: Statement of changes in beneficial ownership of securities

Wang Jonathan Jian: Statement of changes in beneficial ownership of securities

ORBIMED ADVISORS LLC: Major Shareholders

Kinnaird-Steen Barbara: Statement of changes in beneficial ownership of securities

ISALY SAMUEL D: Statement of changes in beneficial ownership of securities

SEVERSON CLINTON: Statement of changes in beneficial ownership of securities

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statement relating to a merger, acquisition, or disposition

Preliminary revised proxy soliciting materials

Preliminary revised proxy soliciting materials

Preliminary proxy statement relating to a merger, acquisition, or disposition

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements